DVT - discharge; Blood clot in the legs - discharge; Thromboembolism - discharge; Venous thromboembolism - deep vein thrombosis; Post-phlebitic syndrome - discharge; Post-thrombotic syndrome - discharge
You were treated for deep vein thrombosis (DVT). This is a condition in which a blood clot forms in a vein that is not on or near the surface of the body.
It mainly affects the large veins in the lower leg and thigh. The clot can block blood flow. If the clot breaks off and moves through the bloodstream, it can get stuck in the blood vessels in the lungs.
Wear the pressure stockings if prescribed by your health care provider. They may improve blood flow in your legs and may lower your risk for long-term complications and problems with blood clots.
Your provider may give you medicine to thin your blood to help keep more clots from forming. The medicines warfarin (Coumadin, Jantoven), rivaroxaban (Xarelto), and apixaban (Eliquis) are examples of blood thinners. If you're prescribed a blood thinner:
Ask your provider what exercises and other activities are safe for you to do.
Do not sit or lie down in the same position for long periods.
If swelling is a problem, keep your legs resting above your heart. When sleeping, make the foot of the bed a few inches higher than the head of the bed.
When traveling:
Do not smoke. If you do, ask your provider for help quitting.
Drink at least 6 to 8 cups (1.5 to 2 liters) of liquid a day, if your provider says it is OK.
Use less salt.
Contact your provider if:
Centers for Disease Control and Prevention website. Venous thromboembolism (blood clots). www.cdc.gov/blood-clots/about/?CDC_AAref_Val=https://www.cdc.gov/ncbddd/dvt/facts.html. Updated May 15, 2024. Accessed May 28, 2024.
Kabrhel C. Pulmonary embolism and deep vein thrombosis. In: Walls RM, ed. Rosen's Emergency Medicine: Concepts and Clinical Practice. 10th ed. Philadelphia, PA: Elsevier; 2023:chap 74.
Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: Second update of the CHEST guideline and expert panel report. Chest. 2021;160(6):e545-e608. PMID: 34352278 pubmed.ncbi.nlm.nih.gov/34352278/.
BACK TO TOPReview Date: 3/31/2024
Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Health Content Provider
06/01/2025
|
A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued. |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.